Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117349951 | 11734995 | 1 | I | 2014 | 20151106 | 20151113 | 20151113 | EXP | US-PFIZER INC-2015382440 | PFIZER | 73.00 | YR | F | Y | 0.00000 | 20151113 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117349951 | 11734995 | 1 | PS | DETROL | TOLTERODINE TARTRATE | 1 | Oral | 4 MG PILL, DAILY (EVERY DAY FOR 10 YEARS) | 20771 | 4 | MG | FILM-COATED TABLET | |||||||
| 117349951 | 11734995 | 2 | SS | OXYBUTYNIN | OXYBUTYNIN | 1 | 10 MG, UNK | 0 | 10 | MG | TABLET | ||||||||
| 117349951 | 11734995 | 3 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 10 MG, UNK | 0 | 10 | MG | ||||||||
| 117349951 | 11734995 | 4 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Oral | 150 MG, DAILY, EARLY IN THE MORNING | 0 | 150 | MG | ||||||||
| 117349951 | 11734995 | 5 | C | METOPROLOL | METOPROLOL | 1 | Oral | 50 MG, DAILY | 0 | 50 | MG | ||||||||
| 117349951 | 11734995 | 6 | C | ATORVASTATIN | ATORVASTATIN | 1 | Oral | 10 MG, 1X/DAY | 0 | 10 | MG | QD | |||||||
| 117349951 | 11734995 | 7 | C | MONTELUKAST | MONTELUKAST SODIUM | 1 | Oral | 10 MG, DAILY | 0 | 10 | MG | ||||||||
| 117349951 | 11734995 | 8 | C | PROAIR HFA | ALBUTEROL SULFATE | 1 | INHALER, 2X/DAY | 0 | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117349951 | 11734995 | 3 | Blood pressure abnormal |
| 117349951 | 11734995 | 4 | Thyroid disorder |
| 117349951 | 11734995 | 5 | Cardiac disorder |
| 117349951 | 11734995 | 6 | Blood cholesterol abnormal |
| 117349951 | 11734995 | 7 | Asthma |
| 117349951 | 11734995 | 8 | Asthma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117349951 | 11734995 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117349951 | 11734995 | Bronchitis | |
| 117349951 | 11734995 | Depression | |
| 117349951 | 11734995 | Glaucoma | |
| 117349951 | 11734995 | Intraocular pressure increased | |
| 117349951 | 11734995 | Meniscus injury | |
| 117349951 | 11734995 | Pneumonia | |
| 117349951 | 11734995 | Pyrexia | |
| 117349951 | 11734995 | Upper respiratory tract infection | |
| 117349951 | 11734995 | Vision blurred |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 117349951 | 11734995 | 2 | 2014 | 0 |